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Conclusion: CPM and QM set by ACC/AHA
are not always met during care of post-AMI
patients. One common barrier is documenting
contraindications to recommended therapies.
Quality improvement projects should be
implemented to optimize the rate of CPM and
QM met. 
https://doi.org/10.32873/unmc.dc.gmerj.2.1.058
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Background: The use of left ventricular
assist devices (LVAD), both as bridge to
cardiac transplantation as well as destination
        
last few years. The vast majority of these
patients are eligible for electrical implantable
devices (including single, dual chamber, and
       
 
of data on the impact of LVAD placement on
the right ventricular lead integrity in these
devices

Twenty seven patients had single or dual
chamber ICD (54%) while 23 patients had a
biventricular ICD (46%). Right ventricular
lead malfunction was reported in 18 patients
(36%) within 6 months of LVAD implantation.
The type of left ventricular assist devices
          

different in the RV lead malfunction group
compared to the rest of the patients.
Conclusion: There is a high incidence of right
ventricular lead dysfunction post implantation
of left ventricular assist devices. 
https://doi.org/10.32873/unmc.dc.gmerj.2.1.078

Methods: We studied a total of 50 patients
who had implantable cardioverter device
(single, dual chamber and biventricular
device) prior to LVAD placement at the
University of Nebraska between 2017
and 2019, a chart review was done to
identify patients with right ventricular lead
dysfunction that was diagnosed post LVAD
implantation.
Results: The mean age of patients at the time
of LVAD was 54 (+/-14) years, the study
included 41 males (82%). Forty-two patients
had Heartmate III, four had Heartmate II
and four patients had Heartware LVAD.
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Background: Parkinson’s disease (PD)
management focuses on quality of life,
including adequate nutrition. Extensive
literature has correlated nutritional
64 Poster Presentations

           
commonly missed. Many new neurological
symptoms are attributed to disease
progression without ruling out these treatable
conditions.
Methods: We present three cases of PD
patients with diverse neurological symptoms
whose workup showed reversible vitamin
    

Results: Case 1 This 81-year-old male
physician with PD developed weight
loss, irritability, and dementia attributed
to advanced disease. Workup revealed
low thiamine (B1) of 30 nmol/L (70-180),
pyridoxine (B6) of 5.2 nmol/L (20.0-125.0),
cobalamin (B12) of 72 pg/mL (180-914), and
25-hydroxyvitamin D of 14 ng/mL (30-80).
He was noncompliant with replacement and
passed away. Case 2 This 90-year-old woman
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with PD developed acute confusion and
          
to PD. She was considered for discharge
until a dietary history revealed that a typical
meal was diet soda and white bread. Serum
B1 (49 nmol/L), B6 (<5.0 nmol/L), and
folate (5.4 ng/mL) were low. Confusion
and hallucinations resolved three days
after replacement. Case 3 This 46-year-old
policeman with PD presented for a second

opinion in the Comprehensive PD Clinic.
He complained of trouble walking and
forgetfulness thought related to his PD. B12
was low (176 pg/mL) and normalized with
replacement. Symptoms resolved within eight
weeks.

            
easily correctable. We are currently collecting
nutritional data on our PD patients for future
studies. 
https://doi.org/10.32873/unmc.dc.gmerj.2.1.079

Conclusion: Common symptoms of PD
including gait problems, cognitive impairment,
hallucinations, and sensory disturbances can
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Background: In this study we assess vitamin
   
!  "    #  
their impact on disease characteristics and
common clinical assessments.
Methods: 118 patients from our PD clinic
underwent serum testing for thiamine
(B1), pyridoxine (B6), cobalamin (B12)
and 25-hydroxy cholecalciferol (D3). We
compared age, BMI, disease duration, United
Parkinson’s Disease Rating Scale (UPDRS),
Mini Mental Status Examination (MMSE),
levodopa equivalent daily dose (LEDD), and
reported falls between those with and without

       $     
included a nonparametric Wilcoxon twosample test and nonparametric Pearson and
Spearman correlations.
Results: In total, 66 patients (56%) were
         &'  
more (B1 = 6, B6 = 26, B12 = 44, and D3
= 24). Average UPDRS score was 35 with
average disease duration of 7 years for both
  *:        
higher (712 mg) compared to the normal
group (594 mg), though not statistically
   #;>??      
       #@G  XYZ
years; p=0.093). Both groups had similar
MMSE scores and report of falls. There were
no linear correlations between vitamin levels
and age, BMI, disease duration, UPDRS,
MMSE, or LEDD.

Conclusion: Our preliminary data suggest
        
present in 56% of our PD patients, there was
not a strong correlation between serum levels
and objective clinical measurements. Sample
size limited statistical power and we will
repeat analyses as more patients are enrolled.
There are many other objective measures that
can be included in future studies. 
https://doi.org/10.32873/unmc.dc.gmerj.2.1.080
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Background: Asthma exacerbation is a
leading cause of emergency department
visits and one of the top indications for
hospitalization in children. Not only does this
burden the medical care system with accruing
costs and resources, these exacerbations are
highly preventable given a strong medical
home and a practical model of pediatric
asthma care. Our aim was to perform a
systemic review of literature to evaluate the
existent models of pediatric asthma care with
clinical and public health outcomes.
Methods: The Up to Date, Cochrane Library,
and PubMed databases were queried using
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the search terms “Models of Pediatric Asthma
Care”. We included all original, full-text
abstracts published after 2010. We excluded
abstracts pertaining to novel agents in
treatment, ED/inpatient management, schoolbased protocols, complementary/alternative
medication, environmental and epigenetic
factors.
Results: The proposed models in literature
are as follows:
1.

Subgroup Analyses from the Prompting
Asthma Intervention in RochesterUniting Parents and Providers Trial
(Goldstein et all, 2018).

2.

Children’s Hospital Boston Community
Asthma Initiative (Sommer et all, 2011).

3.

Medical Home Model (Rojanasarot et
all, 2018).

4.

Ensemble Learning Model (Khasha R et
all, 2019).

5.

Practice Organization Model (Ruffner
MA et all, 2018).

Conclusion: Asthma continues to be a major
public health problem despite novel treatment
agents and guideline-based management.
An ideal theoretical model would include
a) family educational programs/community
resources, b) severity/control assessment,
d)ensuring access of medication/ insurance
coverage, e) addressing environmental
triggers, f)frequent follow up care for
susceptible children, g) addressing co-morbid
conditions, and h) implementing legislative
policy change. 
https://doi.org/10.32873/unmc.dc.gmerj.2.1.082
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